Physician profile
Dixie Shrum
NPI 1598845430
$645.27
in general payments reported to CMS, 2019-2025
15 companies · $47.21 in 2025
The $47.21 reported for 2025 was less than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $173 · 2022: $116 · 2023: $218 · 2024: $91.73 · 2025: $47.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $356.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $80.79 | 2021-2024 | Wegovy |
| Amgen INC. | $80.46 | 2023-2025 | Repatha, Otezla, Repatha |
| Glaxosmithkline, LLC. | $73.11 | 2021-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $70.21 | 2023-2025 | |
| Abbvie INC. | $63.47 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $58.59 | 2021 | |
| Davol INC. | $55.00 | 2021 | |
| Janssen Pharmaceuticals, INC | $31.53 | 2022-2023 | Spravato |
| Exact Sciences Corporation | $30.81 | 2023 | Cologuard Collection Kit |
| Supernus Pharmaceuticals, INC. | $28.11 | 2022 | |
| Genentech USA, INC. | $19.76 | 2021 | |
| Sanofi Pasteur INC. | $16.45 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $13.72 | 2022 | |
| Lilly USA, LLC | $11.66 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $11.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dixie Shrum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.